Amoéba S.A. (FRA:A1H)

Market Cap	59.04M +3.1%
Revenue (ttm)	695.45K +15.6%
Net Income	-8.30M
EPS	-0.14
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.8110
Previous Close	0.8350
Day's Range	0.8110 - 0.8110
52-Week Range	0.7710 - 1.2500
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 17, 2026

About Amoéba

Amoéba S.A. develops biological products and services for the treatment of microbiological risk in the sectors of water, health, and plant protection in France. The company has developed technology to treat water, surfaces, and chronic wounds that uses the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky; and agriculture biocontrol technology for the treatment of phytopathogenic microorganisms using the lysed. Amoéba S.A. was incorporated in 2010 and is headquartered in Chassieu, France.

• Industry: Miscellaneous Chemical Products
• Founded: 2010
• Employees: 23
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: A1H

Financial Performance

In 2025, Amoéba's revenue was 695,449, an increase of 15.60% compared to the previous year's 601,600. Losses were -8.30 million, 26.0% more than in 2024.